In today’s session Albemarle Corporation (ALB) recorded an unusually high (746) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious ALB decrease. With 746 contracts traded and 474 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: ALB161118P00085000 closed last at: $2.6 or 33.3% down. About 452,621 shares traded hands. Albemarle Corporation (NYSE:ALB) has risen 27.92% since April 7, 2016 and is uptrending. It has outperformed by 23.14% the S&P500.
Albemarle Corporation (NYSE:ALB) Ratings Coverage
Out of 11 analysts covering Albemarle Corporation (NYSE:ALB), 8 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 73% are positive. $95 is the highest target while $52 is the lowest. The $75.78 average target is -4.63% below today’s ($79.46) stock price. Albemarle Corporation has been the topic of 23 analyst reports since August 7, 2015 according to StockzIntelligence Inc. Deutsche Bank maintained Albemarle Corporation (NYSE:ALB) rating on Thursday, May 12. Deutsche Bank has “Buy” rating and $84 price target. The rating was upgraded by Citigroup to “Buy” on Monday, November 2. Suntrust Robinson upgraded the shares of ALB in a report on Friday, August 7 to “Buy” rating. JP Morgan maintained Albemarle Corporation (NYSE:ALB) on Tuesday, February 23 with “Neutral” rating. The rating was maintained by Jefferies on Tuesday, December 29 with “Buy”. Deutsche Bank maintained the stock with “Buy” rating in Thursday, August 20 report. Seaport Global downgraded Albemarle Corporation (NYSE:ALB) on Thursday, March 10 to “Neutral” rating. The firm earned “Neutral” rating on Wednesday, November 11 by UBS. On Monday, April 18 the stock rating was maintained by Citigroup with “Buy”. The stock has “Buy” rating given by Citigroup on Tuesday, August 9.
According to Zacks Investment Research, “Albemarle Corporation is a major producer of fine and performance chemicals including polymer intermediates, cleaning product intermediates and additives, agricultural chemical intermediates, pharmaceutical intermediates, catalysts, brominated flame retardants, bromine chemicals and potassium and chlorine chemicals.”
Insitutional Activity: The institutional sentiment increased to 1.36 in Q2 2016. Its up 0.26, from 1.1 in 2016Q1. The ratio increased, as 31 funds sold all Albemarle Corporation shares owned while 112 reduced positions. 80 funds bought stakes while 115 increased positions. They now own 96.46 million shares or 7.92% less from 104.76 million shares in 2016Q1.
Hahn Cap Management Llc, a California-based fund reported 317,786 shares. The New York-based Pointstate L P has invested 0.01% in Albemarle Corporation (NYSE:ALB). Moreover, Mitsubishi Ufj And Banking Corporation has 0.04% invested in Albemarle Corporation (NYSE:ALB) for 223,052 shares. Alyeska Group Inc L P last reported 0.53% of its portfolio in the stock. Systematic Mngmt Lp holds 0.65% or 601,470 shares in its portfolio. Meeder Asset Management holds 0.1% of its portfolio in Albemarle Corporation (NYSE:ALB) for 13,434 shares. Moreover, Driehaus Mngmt Ltd Com has 0.02% invested in Albemarle Corporation (NYSE:ALB) for 7,200 shares. Rafferty Asset Mngmt Ltd Liability Company has 7,432 shares for 0.04% of their US portfolio. Brookside Capital Mngmt Ltd Limited Liability Company has 1.04M shares for 3.46% of their US portfolio. Clinton Grp holds 0.02% of its portfolio in Albemarle Corporation (NYSE:ALB) for 4,590 shares. Clifford Swan Inv Counsel Ltd Co accumulated 0.21% or 39,000 shares. The Japan-based Shinko Asset Mgmt Communications Ltd has invested 0% in Albemarle Corporation (NYSE:ALB). Moreover, Cleararc Cap has 0.05% invested in Albemarle Corporation (NYSE:ALB) for 2,981 shares. Checchi Capital Advisers Limited Co holds 1,007 shares or 0.01% of its portfolio. Stelliam Inv Management Lp last reported 1.57% of its portfolio in the stock.
Insider Transactions: Since May 12, 2016, the stock had 0 buys, and 2 selling transactions for $4.51 million net activity. $352,978 worth of Albemarle Corporation (NYSE:ALB) was sold by SHERMAN JOHN JR. The insider LaBauve Donald J. Jr. sold $268,514. KISSAM LUTHER C IV had sold 50,000 shares worth $4.16M on Wednesday, August 24. On Thursday, May 12 Juneau Matthew sold $992,529 worth of the stock or 13,174 shares.
Albemarle Corporation is a developer, maker and marketer of specialty chemicals across a range of end markets, including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, heating, ventilation, and aluminum finishing. The company has a market cap of $8.57 billion. The Firm operates through three divisions: Performance Chemicals, Refining Solutions and Chemetall Surface Treatment. It has a 15.6 P/E ratio. The Company’s Performance Chemicals segment consists of three product categories: Lithium, Performance Catalyst Solutions and Bromine.
ALB Company Profile
Albemarle Corporation, incorporated on November 24, 1993, is a developer, maker and marketer of specialty chemicals across a range of end markets, including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, crop protection, household appliances, heating, ventilation, aluminum finishing, food safety and custom chemistry services. The Firm operates through three divisions: Performance Chemicals, Refining Solutions and Chemetall Surface Treatment.
More important recent Albemarle Corporation (NYSE:ALB) news were published by: Prnewswire.com which released: “Albemarle Corporation to host 2017 Investor Day in New York City” on November 04, 2016, also Prnewswire.com published article titled: “Albemarle Corporation to present at Morgan Stanley Global Chemicals and …”, Prnewswire.com published: “Albemarle Corporation to release third quarter 2016 earnings results on …” on October 06, 2016. More interesting news about Albemarle Corporation (NYSE:ALB) was released by: Seekingalpha.com and their article: “Albemarle: Expect Shares To Trade Horizontally Till Year-End” with publication date: November 01, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.